dioctanoylphosphatidic acid has been researched along with cyclin d1 in 1 studies
| Studies (dioctanoylphosphatidic acid) | Trials (dioctanoylphosphatidic acid) | Recent Studies (post-2010) (dioctanoylphosphatidic acid) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 13 | 0 | 2 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiles, TC; Dufort, FJ; Gradziel, CS; Jewel, D; Jordan, PA; Miller, SJ; Roberts, MF | 1 |
1 other study(ies) available for dioctanoylphosphatidic acid and cyclin d1
| Article | Year |
|---|---|
d-3-Deoxy-dioctanoylphosphatidylinositol induces cytotoxicity in human MCF-7 breast cancer cells via a mechanism that involves downregulation of the D-type cyclin-retinoblastoma pathway.
Topics: Breast Neoplasms; Cell Death; Cyclin D1; Down-Regulation; Female; Humans; Magnetic Resonance Spectroscopy; MCF-7 Cells; p38 Mitogen-Activated Protein Kinases; Phosphatidic Acids; Phosphatidylinositols; Phosphorylation; Pleckstrin Homology Domains; Proto-Oncogene Proteins c-akt; Retinoblastoma Protein; RNA, Small Interfering; Signal Transduction | 2016 |